AU6472280A - 5-amino-(3,4-bipyridin)-6(1h)-one-1:-oxide - Google Patents

5-amino-(3,4-bipyridin)-6(1h)-one-1:-oxide

Info

Publication number
AU6472280A
AU6472280A AU64722/80A AU6472280A AU6472280A AU 6472280 A AU6472280 A AU 6472280A AU 64722/80 A AU64722/80 A AU 64722/80A AU 6472280 A AU6472280 A AU 6472280A AU 6472280 A AU6472280 A AU 6472280A
Authority
AU
Australia
Prior art keywords
bipyridin
amino
oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64722/80A
Other languages
English (en)
Inventor
George Yohe Lesher
Chester Joseph Opalka Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of AU6472280A publication Critical patent/AU6472280A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/22—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU64722/80A 1979-12-03 1980-11-26 5-amino-(3,4-bipyridin)-6(1h)-one-1:-oxide Abandoned AU6472280A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9950379A 1979-12-03 1979-12-03
US99503 1979-12-03

Publications (1)

Publication Number Publication Date
AU6472280A true AU6472280A (en) 1981-06-11

Family

ID=22275318

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64722/80A Abandoned AU6472280A (en) 1979-12-03 1980-11-26 5-amino-(3,4-bipyridin)-6(1h)-one-1:-oxide

Country Status (18)

Country Link
JP (1) JPS56103165A (fr)
KR (1) KR830004247A (fr)
AU (1) AU6472280A (fr)
BE (1) BE886437A (fr)
DE (1) DE3045637A1 (fr)
DK (1) DK513180A (fr)
ES (1) ES497345A0 (fr)
FI (1) FI803738L (fr)
FR (1) FR2471982A1 (fr)
GB (1) GB2064533A (fr)
IL (1) IL61537A0 (fr)
IT (1) IT8026375A0 (fr)
LU (1) LU82975A1 (fr)
NL (1) NL8006511A (fr)
NO (1) NO803595L (fr)
PT (1) PT72122B (fr)
SE (1) SE8008456L (fr)
ZA (1) ZA807431B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD298781A5 (de) * 1990-03-09 1992-03-12 Inst Wirkstofforschung Verfahren zur herstellung von 5,4'-bipyridin-1'-oxiden
CA2591413A1 (fr) 2004-12-16 2006-06-22 Vertex Pharmaceuticals Incorporated Pyrid-2-ones utiles comme inhibiteurs de proteine kinases de la famille tec pour le traitement de maladies inflammatoires, proliferatives et a mediation immunologique

Also Published As

Publication number Publication date
BE886437A (fr) 1981-06-02
IT8026375A0 (it) 1980-12-02
LU82975A1 (fr) 1981-07-23
ES8200346A1 (es) 1981-10-16
NO803595L (no) 1981-06-04
IL61537A0 (en) 1980-12-31
ZA807431B (en) 1981-11-25
KR830004247A (ko) 1983-07-09
FI803738L (fi) 1981-06-04
GB2064533A (en) 1981-06-17
SE8008456L (sv) 1981-06-04
JPS56103165A (en) 1981-08-18
PT72122A (en) 1980-12-01
DK513180A (da) 1981-06-04
ES497345A0 (es) 1981-10-16
DE3045637A1 (de) 1981-08-27
NL8006511A (nl) 1981-07-01
FR2471982A1 (fr) 1981-06-26
PT72122B (en) 1981-09-29

Similar Documents

Publication Publication Date Title
AU545756B2 (en) Alpha-alkyl-alpha-phenyl-1h-1,2,4-triazole-1-ethanols
AU6416680A (en) 5-fluorouracil derivatives
AU521102B2 (en) 2, 6-diaminonebularines
AU532410B2 (en) Equalizer
AU4152178A (en) 1,9-dihydroxyoctahydrophenanthrenes
AU516088B2 (en) Die-casting
AU534925B2 (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives
AU528144B2 (en) Phenoxypyridine derivatives
AU536113B2 (en) Directional drilling
AU531152B2 (en) 2-chloro-4,5-disubstituted-thiazoles
AU6494680A (en) 2,3-indoledione derivatives
AU527943B2 (en) 2, 4-diamino-5-benzylpyrimidines
AU6472280A (en) 5-amino-(3,4-bipyridin)-6(1h)-one-1:-oxide
AU539995B2 (en) 2,3-dihydro-2,2-dimethylbenzofuran derivatives
AU6108980A (en) 1,2,4-triazole-3-thiols as antisecretory agents
AU529072B2 (en) 25-hydroxycholecalciferol-26,23-lactone
AU535319B2 (en) 1,2,4-imazine derivatives
AU5542080A (en) Equalizer
AU509583B1 (en) Crane equalizer
AU563856B2 (en) 3, 4-disubstituted -1, 2, 5-thiadiazole -1-oxides
AU505664B2 (en) 2, 1, 3-benzothiadiazoles
AU518292B2 (en) 1,4-benzoxathin-2-carboxamides
AU540320B2 (en) 9,10-ethanoanthracene alkanolamines
AU5914680A (en) Glycolaldehyde-n,o-acetals
AU547833B2 (en) N,n:-bis-(2,3-digydroxypropyle-2,4,6-triiodo-5-)2-keto-l- gulonamido isophtalamide